Artificial Skin Model Replicates Atopic Dermatitis for Personalized Treatment
A latest three-dimensional artificial skin model developed by Korean researchers is poised to revolutionize the study and treatment of atopic dermatitis, likewise known as eczema. The model accurately mimics the complex microenvironment of atopic dermatitis lesions, offering a more realistic platform for drug testing and the development of personalized therapies.
The Limitations of Traditional Research Methods
Historically, atopic dermatitis research has relied heavily on two-dimensional cell cultures and animal models. However, these methods often fail to capture the intricate interplay between structural cells, immune cells, and sensory nerves that characterize human skin. This complexity makes it tricky to accurately predict how drugs will perform in actual patients. A key challenge has been understanding the “hypoxic environment” – areas of low oxygen – found in atopic dermatitis lesions and its role in causing itch.
A New Approach: 3D Artificial Skin
Researchers at Yonsei University College of Medicine, in collaboration with Incheon National University and Korea University, have overcome these limitations with their next-generation artificial skin platform. The team, led by Professor Kim Lark-kyun, Professor Park Kyung-min, and Professor Choi Jung-min, utilized “single-cell RNA sequencing” technology to analyze skin tissue from atopic dermatitis patients at the cellular level. This analysis identified specific fibroblasts (COL6A5⁺) that induce itch [1].
Recreating the Atopic Dermatitis Microenvironment
The researchers then used a special gelatin-based hydrogel to create a three-dimensional structure that supports the survival of these identified cells. Crucially, the model is designed to precisely control oxygen diffusion, recreating the hypoxic conditions found in atopic dermatitis lesions [2]. Key immune stimulating factors were also applied to mimic the inflammatory environment of the disease.
Confirming the Itch Mechanism
Experiments using the artificial skin model demonstrated that cells exposed to the hypoxic environment rapidly released itch-related factors. The model also confirmed the activation of co-cultured sensory neurons in real-time, experimentally proving that itching in atopic dermatitis is caused by a complex interaction between skin structure, the immune system, and the nervous system [1].
Implications for Personalized Medicine
This research represents a significant step forward in personalized medicine for atopic dermatitis. By accurately reflecting the characteristics of human disease and reducing reliance on animal testing, the model is expected to be widely used to evaluate the efficacy of new drug candidates and develop patient-tailored treatments. Professor Kim Rak-kyun anticipates the model will establish customized treatment strategies for each patient [2].
Future Directions
The research team plans to continue refining the model and expanding its application to other chronic inflammatory skin diseases. The findings were published in the international academic journal Bioactive Materials [1].